Michael Catelani - Jan 12, 2024 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
President, COO & CFO
Signature
/s/ Michael J. Catelani
Stock symbol
ANIX
Transactions as of
Jan 12, 2024
Transactions value $
$0
Form type
4
Date filed
1/16/2024, 07:07 PM
Previous filing
Nov 2, 2023
Next filing
May 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +350K $0.00 350K Jan 12, 2024 Common Stock 350K $4.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024.